TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 55 filers reported holding TALARIS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $44,392 | – | 43,522 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $8,240,623 | 10.94% |
| BML Capital Management, LLC | 2,000,000 | $5,620,000 | 5.16% |
| Nantahala Capital Management | 2,953,129 | $8,298,292 | 0.71% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $2,810,000 | 0.51% |
| Acuitas Investments, LLC | 194,547 | $546,677 | 0.32% |
| Affinity Asset Advisors, LLC | 400,000 | $1,124,000 | 0.32% |
| RA Capital Management | 2,403,238 | $6,753,099 | 0.13% |
| Artal Group S.A. | 914,262 | $2,569 | 0.11% |
| Blackstone Inc. | 8,089,315 | $22,730,975 | 0.10% |
| QVT Financial LP | 589,314 | $1,655,972 | 0.09% |